Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series

Introduction: Mantle-cell lymphoma (MCL) with relapsed/refractory (R/R) disease after intensive chemotherapy have few effective treatment options. Ibrutinib showed a promising median progression-free survival (PFS) with manageable toxicity. The BCL2 inhibitor venetoclax showed encouraging results in...

Full description

Saved in:
Bibliographic Details
Published in:Am J Blood Res
Main Authors: Fabbri, Alberto, Cencini, Emanuele, Congiu, Angela Giovanna, Miglino, Maurizio, Rigacci, Luigi, Bocchia, Monica
Format: Artigo
Language:Inglês
Published: e-Century Publishing Corporation 2020
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7811909/
https://ncbi.nlm.nih.gov/pubmed/33489445
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items